Tumor-treating fields: time for demystification
Gespeichert in:
Veröffentlicht in: | Annals of oncology 2018-08, Vol.29 (8), p.1628-1630 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1630 |
---|---|
container_issue | 8 |
container_start_page | 1628 |
container_title | Annals of oncology |
container_volume | 29 |
creator | Weller, M. |
description | |
doi_str_mv | 10.1093/annonc/mdy220 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2056400457</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/annonc/mdy220</oup_id><els_id>S0923753419341365</els_id><sourcerecordid>2056400457</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3280-827c763cd83a3b30c04ab6e8fb883ba2dd5f1de3ee1a83c4c915e74794b7f4093</originalsourceid><addsrcrecordid>eNqFkD1PwzAQQC0EoqUwsqKOLKH-jG02hPiSKrGU2XLsCzJK4mInSP33BKXAhJhuefdO9xA6J_iKYM1Wtuti51at31GKD9CciFIXCnNyiOZYU1ZIwfgMneT8hjEuNdXHaEa1xkKKco5Wm6GNqegT2D50r8s6QOPz9bIPLSzrmJYe2l3uQx3cCMTuFB3Vtslwtp8L9HJ_t7l9LNbPD0-3N-vCMapwoah0smTOK2ZZxbDD3FYlqLpSilWWei9q4oEBEKuY404TAZJLzStZ8_GvBbqcvNsU3wfIvWlDdtA0toM4ZEOxKDnGXMgRLSbUpZhzgtpsU2ht2hmCzVcjMzUyU6ORv9irh6oF_0N_R_m9HYftvy45oTC2-AiQTHYBOgc-JHC98TH8sfkJcriFYA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2056400457</pqid></control><display><type>article</type><title>Tumor-treating fields: time for demystification</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Weller, M.</creator><creatorcontrib>Weller, M.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy220</identifier><identifier>PMID: 29905756</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antineoplastic Agents, Alkylating - therapeutic use ; Brain Neoplasms - mortality ; Brain Neoplasms - therapy ; Combined Modality Therapy - methods ; Electric Stimulation Therapy - methods ; Glioblastoma - mortality ; Glioblastoma - therapy ; Humans ; Neoplasm Recurrence, Local - mortality ; Neoplasm Recurrence, Local - therapy ; Progression-Free Survival ; Randomized Controlled Trials as Topic ; Temozolomide - therapeutic use</subject><ispartof>Annals of oncology, 2018-08, Vol.29 (8), p.1628-1630</ispartof><rights>2018 THE AUTHORS</rights><rights>The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3280-827c763cd83a3b30c04ab6e8fb883ba2dd5f1de3ee1a83c4c915e74794b7f4093</citedby><cites>FETCH-LOGICAL-c3280-827c763cd83a3b30c04ab6e8fb883ba2dd5f1de3ee1a83c4c915e74794b7f4093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29905756$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Weller, M.</creatorcontrib><title>Tumor-treating fields: time for demystification</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><subject>Antineoplastic Agents, Alkylating - therapeutic use</subject><subject>Brain Neoplasms - mortality</subject><subject>Brain Neoplasms - therapy</subject><subject>Combined Modality Therapy - methods</subject><subject>Electric Stimulation Therapy - methods</subject><subject>Glioblastoma - mortality</subject><subject>Glioblastoma - therapy</subject><subject>Humans</subject><subject>Neoplasm Recurrence, Local - mortality</subject><subject>Neoplasm Recurrence, Local - therapy</subject><subject>Progression-Free Survival</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Temozolomide - therapeutic use</subject><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkD1PwzAQQC0EoqUwsqKOLKH-jG02hPiSKrGU2XLsCzJK4mInSP33BKXAhJhuefdO9xA6J_iKYM1Wtuti51at31GKD9CciFIXCnNyiOZYU1ZIwfgMneT8hjEuNdXHaEa1xkKKco5Wm6GNqegT2D50r8s6QOPz9bIPLSzrmJYe2l3uQx3cCMTuFB3Vtslwtp8L9HJ_t7l9LNbPD0-3N-vCMapwoah0smTOK2ZZxbDD3FYlqLpSilWWei9q4oEBEKuY404TAZJLzStZ8_GvBbqcvNsU3wfIvWlDdtA0toM4ZEOxKDnGXMgRLSbUpZhzgtpsU2ht2hmCzVcjMzUyU6ORv9irh6oF_0N_R_m9HYftvy45oTC2-AiQTHYBOgc-JHC98TH8sfkJcriFYA</recordid><startdate>201808</startdate><enddate>201808</enddate><creator>Weller, M.</creator><general>Elsevier Ltd</general><general>Oxford University Press</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201808</creationdate><title>Tumor-treating fields: time for demystification</title><author>Weller, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3280-827c763cd83a3b30c04ab6e8fb883ba2dd5f1de3ee1a83c4c915e74794b7f4093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antineoplastic Agents, Alkylating - therapeutic use</topic><topic>Brain Neoplasms - mortality</topic><topic>Brain Neoplasms - therapy</topic><topic>Combined Modality Therapy - methods</topic><topic>Electric Stimulation Therapy - methods</topic><topic>Glioblastoma - mortality</topic><topic>Glioblastoma - therapy</topic><topic>Humans</topic><topic>Neoplasm Recurrence, Local - mortality</topic><topic>Neoplasm Recurrence, Local - therapy</topic><topic>Progression-Free Survival</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Temozolomide - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Weller, M.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Weller, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumor-treating fields: time for demystification</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-08</date><risdate>2018</risdate><volume>29</volume><issue>8</issue><spage>1628</spage><epage>1630</epage><pages>1628-1630</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>29905756</pmid><doi>10.1093/annonc/mdy220</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0923-7534 |
ispartof | Annals of oncology, 2018-08, Vol.29 (8), p.1628-1630 |
issn | 0923-7534 1569-8041 |
language | eng |
recordid | cdi_proquest_miscellaneous_2056400457 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Antineoplastic Agents, Alkylating - therapeutic use Brain Neoplasms - mortality Brain Neoplasms - therapy Combined Modality Therapy - methods Electric Stimulation Therapy - methods Glioblastoma - mortality Glioblastoma - therapy Humans Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - therapy Progression-Free Survival Randomized Controlled Trials as Topic Temozolomide - therapeutic use |
title | Tumor-treating fields: time for demystification |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T13%3A50%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumor-treating%20fields:%20time%20for%20demystification&rft.jtitle=Annals%20of%20oncology&rft.au=Weller,%20M.&rft.date=2018-08&rft.volume=29&rft.issue=8&rft.spage=1628&rft.epage=1630&rft.pages=1628-1630&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy220&rft_dat=%3Cproquest_cross%3E2056400457%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2056400457&rft_id=info:pmid/29905756&rft_oup_id=10.1093/annonc/mdy220&rft_els_id=S0923753419341365&rfr_iscdi=true |